Press Releases
Search
-
09 Apr 2024
Press Release
First-Quarter 2024 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the three months ended March 31th, 2024.
-
05 Apr 2024
Press Release
bioMérieux and Mérieux NutriSciences partner with key food industry players to launch a new collaborative data-driven model
bioMérieux and Mérieux NutriSciences jointly announce the launch of a new data-driven Trusted Third Party initiative, built with a group of global food industry partners to foster safe industry collaboration as well as better anticipate and prevent food safety risks.
-
27 Mar 2024
Press Release
Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel
bioMérieux, a world leader in the field of in vitro diagnostics, has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel.
-
14 Mar 2024
Press Release
bioMérieux – 2023 Financial Results
Today bioMérieux released its 2023 financial results. Consolidated sales amounted to €3,675 million in 2023, up 6.6% like-for-like from €3,589 million in the prior year period.
-
16 Jan 2024
Appointments
bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
bioMérieux, a world leader in the field of in vitro diagnostics, announces the appointment of two new Executive Committee members: Dr. Charles K. Cooper as Executive Vice President, Chief Medical Officer, effective January 2nd, 2024; Céline Roger-Dalbert as Executive Vice President Research and Development, effective March 1st, 2024.
-
08 Jan 2024
Mergers & Acquisitions
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.